XELOX vs. FOLFOX in metastatic colorectal cancer: An updated meta-analysis.
about
FOLFOX regimen plus dendritic cells-cytokine-induced killer cells immunotherapy for the treatment of colorectal cancer: a meta-analysis.Cytokine-induced killer cells/dendritic cells-cytokine induced killer cells immunotherapy combined with chemotherapy for treatment of colorectal cancer in China: a meta-analysis of 29 trials involving 2,610 patients.An Update on Randomized Clinical Trials in Metastatic Colorectal Carcinoma.A Network Pharmacology Approach to Uncover the Multiple Mechanisms of Hedyotis diffusa Willd. on Colorectal Cancer.New Trends in the Therapeutic Approach to Metastatic Colorectal Cancer.
P2860
XELOX vs. FOLFOX in metastatic colorectal cancer: An updated meta-analysis.
description
2016 nî lūn-bûn
@nan
2016 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
XELOX vs. FOLFOX in metastatic colorectal cancer: An updated meta-analysis.
@ast
XELOX vs. FOLFOX in metastatic colorectal cancer: An updated meta-analysis.
@en
type
label
XELOX vs. FOLFOX in metastatic colorectal cancer: An updated meta-analysis.
@ast
XELOX vs. FOLFOX in metastatic colorectal cancer: An updated meta-analysis.
@en
prefLabel
XELOX vs. FOLFOX in metastatic colorectal cancer: An updated meta-analysis.
@ast
XELOX vs. FOLFOX in metastatic colorectal cancer: An updated meta-analysis.
@en
P2093
P2860
P1433
P1476
XELOX vs. FOLFOX in metastatic colorectal cancer: An updated meta-analysis.
@en
P2093
P2860
P304
P356
10.3109/07357907.2015.1104689
P577
2016-02-11T00:00:00Z